EEF2K and triple-negative breast carcinoma: The study by Wang and colleagues (2019) [39] investigated the role of autophagy and its regulator, eukaryotic elongation factor 2 kinase (eEF2K), in determining the biological nature of triple-negative breast cancers (TNBCs).